Across TCGA pan-cancer cohorts, VN1R91P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of VN1R91P’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where VN1R91P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types VN1R91P is over-expressed in tumor.
STAD are the cancer types where VN1R91P tumor–normal differential expression is most reproducible.